What is the Impact Factor of Clinical & Experimental Metastasis?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical & Experimental Metastasis is 3.70, ranking in quartile Q2 of Web of Science (SCIE).

Is Clinical & Experimental Metastasis indexed in Web of Science or Scopus?

Yes, Clinical & Experimental Metastasis is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.187 (Q1) and an H-index of 114.

Who publishes Clinical & Experimental Metastasis and what is the Article Processing Charge (APC)?

Clinical & Experimental Metastasis is published by Springer Netherlands. The estimated Article Processing Charge (APC) is approximately $3,437 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical & Experimental Metastasis?

The official ISO-4 abbreviation of Clinical & Experimental Metastasis is "CLIN EXP METASTAS". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #3,703Hybrid

Clinical & Experimental Metastasis

Abbreviation (ISO):CLIN EXP METASTAS

•

Identifier (ISSN):0262-0898(Print)/1573-7276(Online)

•

Publisher:Springer Netherlands

Official Website Submission Portal Compare

Clarivate IF (2026)

3.7↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical & Experimental Metastasis

WoS Q2

Annual Impact Factor Metric

Current (2026):3.7

Scopus SJR & RankScopus Q1

1.187

#3,703

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

114

114 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate2.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

67articles/year

46.75% Gold OA•73.47% Original Research

Aims & Scope

The Journal's scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal's core subject of metastasis formation, prevention and treatment.

Topics Covered (Recognized by AI)

Medicine99.3%Biology95.8%Internal medicine94.8%Genetics93%Chemistry72.3%Cancer71.8%Biochemistry70.2%Cancer research67.5%Pathology57.8%Immunology52%Surgery51.4%Metastasis50.4%Oncology45.3%Surgical oncology39.3%Gene35.1%Cell biology32.7%Cell culture29.9%Cell28.7%In vitro27.2%Psychology24%Physics23.1%Psychiatry21.8%Endocrinology21.5%Organic chemistry20.9%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank129/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank151/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	129/333	Q2
ONCOLOGY	JCISCIE	151/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.7

Articles / Year39

Total Citations20

2025

IF3.2

Articles / Year59

Total Citations125

2024

IF4.2

Articles / Year75

Total Citations552

2023

IF4

Articles / Year53

Total Citations462

2022

IF4.51

Articles / Year57

Total Citations921

Year	Impact Factor	Articles / Year	Total Citations
2026	3.7	39	20
2025	3.2	59	125
2024	4.2	75	552
2023	4	53	462
2022	4.51	57	921
2021	5.15	72	1,740
2020	3.027	50	902
2019	2.513	69	2,269
2018	3.455	72	2,718
2017	—	45	1,244
2016	—	56	1,657
2015	—	86	3,640

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,703Scopus Q1SCImago Profile

Scopus Coverage:1983-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.187

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.40

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,437 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations749

3-Year Documents197

Citable Documents179

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

Cancer ResearchQ2

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical & Experimental Metastasis (abbr: CLIN EXP METASTAS, ISSN: 0262-0898) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Netherlands in Netherlands since 1983. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.187 (Q1), an H-index of 114.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 67 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,437 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.